Prexton Therapeutics: Vischer advises Lundbeck on acquisition of Prexton Therapeutics

Lundbeck A/S (Lundbeck) and Prexton Therapeutics BV (Prexton) announced the signing of a definitive agreement in which Lundbeck will acquire Prexton. Under terms of the agreement, Lundbeck will pay €100m upfront and is furthermore required to later pay up to €805m in development and sales milestones to the group of current owners. VISCHER advised Lundbeck [...] The post Vischer advises Lundbeck on acquisition of Prexton Therapeutics appeared first on The Lawyer | Legal News and Jobs | Advancing the business of law.